Pro-Larva Face Masks – the first mask proven to kill up to 99.9% of influenza and coronaviruses
We're excited to announce that we've partnered with Pharm2Farm to offer their unique Pro-Larva Anti-Viral Face Mask. It is the first mask of its kind that has been clinically proven to kill up to 99.9% of coronaviruses and influenza for up to 7 hours.
The unique α-virion™ layer of the mask provides enhanced protection for both the wearer and those in proximity compared to equivalent type II masks. The 4 layers of the mask provide a physical barrier for users against pathogens, microorganisms, body fluids and particles.
One of the 4-layers features natural copper nanoparticles which actively kills coronavirus. On contact with the virus, the nanoparticles emit ions that penetrate the surface of the virus, destroying its genetic material causing it to die and stop reproducing. This nanoparticle layer and level of filtration within the mask ensures additional protection to the space around the wearer.
The mask has a longer life than regular type II face masks which means that fewer masks are required with regular use. This reduces medical waste and cost to the user. The mask is also the only one of its kind to be approved by the MHRA and the α-virion™ layer has been certified to ISO 18184 standards.
Designed and developed in the UK using technology from Nottingham Trent University, the Pro-Larva Anti-Viral Face Mask is available now from just £45.00 for a pack of 50. You can buy direct from us here or if you need any further information then you can contact our sales team on 0114 2433896, or by emailing email@example.com.